Portnow, Jana http://orcid.org/0000-0002-4257-0891
Badie, Behnam
Suzette Blanchard, M.
Kilpatrick, Julie
Tirughana, Revathiswari http://orcid.org/0000-0002-9643-510X
Metz, Marianne http://orcid.org/0000-0001-6476-4569
Mi, Shu
Tran, Vivi
Ressler, Julie http://orcid.org/0000-0003-3086-3045
D’Apuzzo, Massimo http://orcid.org/0000-0001-8146-0997
Aboody, Karen S.
Synold, Timothy W. http://orcid.org/0000-0002-4075-2544
Funding for this research was provided by:
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (R01 FD004816)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA033572)
Phase One Foundation
Rosalinde and Arthur Gilbert Foundation
Article History
Received: 29 April 2020
Revised: 4 August 2020
Accepted: 19 August 2020
First Online: 8 September 2020
Compliance with ethical standards
:
: K.S. Aboody is a shareholder and board member of TheraBiologics, Inc.